Amarin Corp Plc (AMRN)

[rafunrafun]

Scripts for week ending March 3, 2023

Drug Industry TRx: +4.6% w/w; +6.9% y/y

Vascepa
TRx 61,405; +7.2% (+4,146) w/w; -18.7% y/y
NRx 28,632; +8.0% (+2,124) w/w; -20.3% y/y
Ref 32,773; +6.6% (+2,022) w/w; -17.3% y/y

Fake Vascepa
TRx 46,074; +3.3% (+1,469) w/w; As % of total V: 42.9%
NRx 22,897; +3.8% (+848) w/w; As % of total V: 44.4%
Ref 23,177; +2.8% (+621) w/w; As % of total V: 41.4%

Fake Vascepa by Manufacturer
Hikma TRx 16,937; Gen share 36.8% Total V share 15.8%
Reddy TRx 19,019; Gen share 41.3%; Total V share 17.7%
Apotex TRx 8,713; Gen share 18.9%; Total V share 8.1%
Teva TRx 692; Gen share 1.5%; Total V share 0.6%
Northstar TRx 714; Gen share 1.5%; Total V share 0.7%

Vascepa + Fake Vascepa
TRx 107,479; +5.5% (+5,615) w/w; +1.3% y/y
NRx 51,530; +6.1% (+2,972) w/w; -4.2% y/y
Ref 55,950; +5.0% (+2,644) w/w; +7.2% y/y

Lovaza (Fake & Brand)
TRx 66,056; +5.4% (+3,377) w/w; +0.8% y/y
NRx 33,037; +3.5% (+1,105) w/w; -3.6% y/y
Ref 33,019; +7.4% (+2,272) w/w; +5.6% y/y